selective IgM deficiency

disease
On this page

Also known as selective IgM deficiency diseaseselective immunoglobulin M deficiencySIgMD

Summary

selective IgM deficiency (MONDO:0018039) is a disease and 1 clinical trial. A subtype of dysgammaglobulinemia — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: Unknown (Worldwide) [Orphanet-validated]
  • Phenotypes (HPO): 64
  • Clinical trials: 1

Clinical features

Signs & symptoms

Clinical features (HPO)

64 HPO clinical features (Orphanet curated; top 50 by frequency):

HPO IDTermFrequency
HP:0002719Recurrent infectionsVery frequent (80-99%)
HP:0032169Severe infectionVery frequent (80-99%)
HP:0002850Decreased circulating total IgMVery frequent (80-99%)
HP:0002205Recurrent respiratory infectionsVery frequent (80-99%)
HP:0002960AutoimmunityFrequent (30-79%)
HP:0012393AllergyFrequent (30-79%)
HP:0032140Decreased specific antibody response to vaccinationFrequent (30-79%)
HP:0002788Recurrent upper respiratory tract infectionsFrequent (30-79%)
HP:0006532Recurrent pneumoniaFrequent (30-79%)
HP:0011108Recurrent sinusitisFrequent (30-79%)
HP:0001047Atopic dermatitisOccasional (5-29%)
HP:0001510Growth delayOccasional (5-29%)
HP:0200043VerrucaeOccasional (5-29%)
HP:0030880Raynaud phenomenonOccasional (5-29%)
HP:0012432Chronic fatigueOccasional (5-29%)
HP:0000491KeratitisOccasional (5-29%)
HP:0011109Chronic sinusitisOccasional (5-29%)
HP:0000010Recurrent urinary tract infectionsOccasional (5-29%)
HP:0002110BronchiectasisOccasional (5-29%)
HP:0032261Nontuberculous mycobacterial pulmonary infectionOccasional (5-29%)
HP:0002725Systemic lupus erythematosusOccasional (5-29%)
HP:0001370Rheumatoid arthritisOccasional (5-29%)
HP:0001973Autoimmune thrombocytopeniaOccasional (5-29%)
HP:0001904Neutropenia in presence of anti-neutropil antibodiesOccasional (5-29%)
HP:0003493Antinuclear antibody positivityOccasional (5-29%)
HP:0012204Recurrent vulvovaginal candidiasisOccasional (5-29%)
HP:0100658CellulitisOccasional (5-29%)
HP:0005353Recurrent herpesOccasional (5-29%)
HP:0000388Otitis mediaOccasional (5-29%)
HP:0025439PharyngitisOccasional (5-29%)
HP:0031691Severe viral infectionOccasional (5-29%)
HP:0033430Non-infectious meningitisOccasional (5-29%)
HP:0011370Recurrent cutaneous fungal infectionsOccasional (5-29%)
HP:0007499Recurrent staphylococcal infectionsOccasional (5-29%)
HP:0002837Recurrent bronchitisOccasional (5-29%)
HP:0031292Cutaneous abscessOccasional (5-29%)
HP:0009098Chronic oral candidiasisOccasional (5-29%)
HP:0002028Chronic diarrheaOccasional (5-29%)
HP:0003193Allergic rhinitisOccasional (5-29%)
HP:0002099AsthmaOccasional (5-29%)
HP:0031047ParaproteinemiaOccasional (5-29%)
HP:0045080Decreased proportion of CD3-positive T cellsOccasional (5-29%)
HP:0032218Decreased proportion of CD4-positive T cellsOccasional (5-29%)
HP:0030380Decreased proportion of transitional B cellsOccasional (5-29%)
HP:0002716LymphadenopathyOccasional (5-29%)
HP:0004798Recurrent infection of the gastrointestinal tractOccasional (5-29%)
HP:0001287MeningitisOccasional (5-29%)
HP:0100806SepsisOccasional (5-29%)
HP:0002720Decreased circulating IgA levelExcluded (0%)
HP:0004315Decreased circulating IgG levelExcluded (0%)

Identifiers

Disease identifiers

FieldValue
Canonical nameselective IgM deficiency
Mondo IDMONDO:0018039
Orphanet331235
DOIDDOID:0050222
SNOMED CT190980000
UMLSC0154275
MedGen57820
GARD0012547
Is cancer (heuristic)no

Also known as: selective IgM deficiency disease · selective immunoglobulin M deficiency · SIgMD

Data availability: 1 cell line.

Disease family

This is a subtype of dysgammaglobulinemia. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › immune system disorderinborn error of immunityB cell deficiencyselective immunoglobulin deficiency diseasedysgammaglobulinemiaselective IgM deficiency

Related subtypes (3): selective IgA deficiency disease, selective IgE deficiency disease, selective IgG immunodeficiency

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified1

Top trials by phase / activity

NCTPhaseStatusTitle
NCT06355323Not specifiedCOMPLETEDBronchiectasis Prevalence in Patients With Primary Humoral Immunodefiency in Champagne-Ardenne Region, France

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.